| 0 (0%) | 12-27 00:26 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.86  |
1-year : | 4.51 |
| Resists | First : | 3.3 |
Second : | 3.86 |
| Pivot price | 2.57 |
|||
| Supports | First : | 2.43 |
Second : | 1.89 |
| MAs | MA(5) : | 2.95 |
MA(20) : | 2.47 |
| MA(100) : | 2.25 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 92.9  |
D(3) : | 94.9 |
| RSI | RSI(14): 80 |
|||
| 52-week | High : | 4.98 | Low : | 1.89 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CRDF ] has closed below upper band by 1.4%. Bollinger Bands are 111.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.31 - 3.33 | 3.33 - 3.35 |
| Low: | 3.06 - 3.07 | 3.07 - 3.09 |
| Close: | 3.14 - 3.17 | 3.17 - 3.19 |
Tue, 23 Dec 2025
Flputnam Investment Management Co. Purchases 543,370 Shares of Cardiff Oncology, Inc. $CRDF - MarketBeat
Wed, 17 Dec 2025
Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Average Rating of "Hold" by Brokerages - MarketBeat
Tue, 09 Dec 2025
CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response - Yahoo Finance
Mon, 24 Nov 2025
Cardiff Oncology (NASDAQ: CRDF) to Join Piper Sandler 37th Conference Fireside Chat - Stock Titan
Sat, 25 Oct 2025
Cardiff Oncology: Preparing For A Defining 2026 - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 67 (M) |
| Held by Insiders | 6.573e+007 (%) |
| Held by Institutions | 5.9 (%) |
| Shares Short | 14,250 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -5.333e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -9 % |
| Return on Assets (ttm) | 978.3 % |
| Return on Equity (ttm) | -53 % |
| Qtrly Rev. Growth | 501000 % |
| Gross Profit (p.s.) | -20.23 |
| Sales Per Share | -76.09 |
| EBITDA (p.s.) | -2.9237e+007 |
| Qtrly Earnings Growth | -0.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -42 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.05 |
| Price to Cash Flow | 5.86 |
| Dividend | 0 |
| Forward Dividend | 1.559e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|